drugset / Trial / NCT03365752

Chloroprocaine Spinal for Outpatient Knee Surgery

NCT03365752

Phase 2 Terminated 39 enrolled Hospital for Special Surgery, New York
RandomizedParallel-groupDouble-blindTreatment

Summary

Outpatient knee surgeries with duration of less than one hour pose a challenge to the use of spinal anesthesia given that traditional agents remain in effect for 2-3 hours, thus creating a mismatch between length of surgery and anesthetic resolution. The investigators hypothesize that the use of chloroprocaine can combine the benefits of a short spinal anesthetic while avoiding the side effects of a general anesthetic, thus promoting earlier discharge.

Timeline

Start
2018-06-24
Primary completion
2021-02-04
Completion
2021-02-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloroprocaine Other / unclassified 40 mg Intrathecal
Comparator Mepivacaine Other / unclassified 45 mg Intrathecal

Indications

No indication recorded.